Recent Patents on Drug Delivery & Formulation
Title:3D Printing in Drug Delivery Formulation: You Can Dream it, Design it and Print it. How About Patent it?
Volume: 9 Issue: 3
Author(s): Viness Pillay and Yahya E. Choonara
Affiliation:
Export Options
About this article
Cite this article as:
Pillay Viness and Choonara E. Yahya, 3D Printing in Drug Delivery Formulation: You Can Dream it, Design it and Print it. How About Patent it?, Recent Patents on Drug Delivery & Formulation 2015; 9 (3) . https://dx.doi.org/10.2174/1872211309666150608094744
DOI https://dx.doi.org/10.2174/1872211309666150608094744 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
Article Metrics
Related Articles
-
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a Mouse Model of Inflammatory Pain
CNS & Neurological Disorders - Drug Targets Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential
Current Pharmaceutical Design Hypoxia as an Initiator of Neuroinflammation: Microglial Connections
Current Neuropharmacology Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Mesenchymal Stem Cell-Based Therapy for the Treatment of Type 1 Diabetes Mellitus
Current Stem Cell Research & Therapy The Role of Proprioception in Osteoarthritis of the Hand and Wrist
Current Rheumatology Reviews Selegiline (l-Deprenyl) as a Unique Neuroprotective Agent for Chronic Neurodegenerative Disorders- A Lesson from MAO Inhibition
Current Medicinal Chemistry - Central Nervous System Agents VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype
CNS & Neurological Disorders - Drug Targets Neuroprotective Role of Agmatine in Neurological Diseases
Current Neuropharmacology The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide
Anti-Cancer Agents in Medicinal Chemistry Current Concepts in Reprogramming Somatic Cells to Pluripotent State
Current Stem Cell Research & Therapy Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents
Current Medicinal Chemistry Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Current Pharmaceutical Design Proteases as Anti-Cancer Targets - Molecular and Biological Basis for Development of Inhibitor-Like Drugs Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Pharmacological Approaches to Functional Recovery After Spinal Injury
Current Drug Targets - CNS & Neurological Disorders